PUNAM PUNJA: Open Payments
NPI 1528381522 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,603 in 42 payments from 3 companies in 2025. Trend: 2023 $64 · 2024 $4,845 · 2025 $25,603
Speaker / faculty: $18,306Travel & lodging: $3,565Consulting: $2,330Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 26 | $14,294 |
| Novo Nordisk Inc | 8 | $8,930 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $2,379 |
Products named: REZDIFFRA, Wegovy, TRULANCE, XIFAXAN.
Industry payments across GA — which companies pay providers there.
